Magdalena Krzystolik, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macular Degeneration | 7 | 2020 | 1014 | 1.070 |
Why?
|
| Angiogenesis Inhibitors | 9 | 2020 | 2056 | 0.980 |
Why?
|
| Blast Injuries | 1 | 2024 | 318 | 0.690 |
Why?
|
| Vascular Endothelial Growth Factor A | 8 | 2020 | 3513 | 0.670 |
Why?
|
| Eye Injuries | 2 | 2021 | 228 | 0.670 |
Why?
|
| Vision, Low | 1 | 2020 | 162 | 0.610 |
Why?
|
| Retinal Vein Occlusion | 2 | 2016 | 149 | 0.580 |
Why?
|
| Coronavirus | 1 | 2020 | 155 | 0.580 |
Why?
|
| Intravitreal Injections | 6 | 2020 | 401 | 0.560 |
Why?
|
| Aptamers, Nucleotide | 4 | 2019 | 163 | 0.550 |
Why?
|
| Economics, Pharmaceutical | 1 | 2016 | 88 | 0.500 |
Why?
|
| Military Personnel | 1 | 2024 | 1252 | 0.470 |
Why?
|
| Athletic Injuries | 1 | 2021 | 1240 | 0.370 |
Why?
|
| Choroidal Neovascularization | 5 | 2019 | 360 | 0.310 |
Why?
|
| Visual Acuity | 7 | 2020 | 2708 | 0.250 |
Why?
|
| Iris | 1 | 2006 | 232 | 0.240 |
Why?
|
| Diabetic Retinopathy | 3 | 2015 | 1299 | 0.230 |
Why?
|
| Macular Edema | 3 | 2015 | 387 | 0.230 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2243 | 0.200 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3100 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3223 | 0.200 |
Why?
|
| Immunoglobulin Fragments | 1 | 2002 | 83 | 0.190 |
Why?
|
| Hyphema | 1 | 2021 | 26 | 0.190 |
Why?
|
| Aspirin | 1 | 2013 | 3134 | 0.190 |
Why?
|
| Play and Playthings | 1 | 2021 | 85 | 0.180 |
Why?
|
| Phacoemulsification | 2 | 2006 | 151 | 0.180 |
Why?
|
| Tropism | 1 | 2020 | 44 | 0.170 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.170 |
Why?
|
| Silicone Oils | 1 | 2000 | 22 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 4 | 2019 | 9249 | 0.170 |
Why?
|
| Porphyrins | 2 | 2014 | 351 | 0.160 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 680 | 0.160 |
Why?
|
| Gases | 1 | 2000 | 206 | 0.160 |
Why?
|
| Lymphokines | 1 | 2002 | 911 | 0.160 |
Why?
|
| Environment | 1 | 2024 | 1114 | 0.150 |
Why?
|
| Endophthalmitis | 2 | 2020 | 263 | 0.140 |
Why?
|
| Aspergillus niger | 1 | 1997 | 18 | 0.140 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2020 | 660 | 0.130 |
Why?
|
| Retinal Detachment | 2 | 2006 | 426 | 0.130 |
Why?
|
| Uveal Diseases | 1 | 1996 | 45 | 0.130 |
Why?
|
| Retinal Perforations | 1 | 1998 | 138 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2006 | 2631 | 0.130 |
Why?
|
| Eye Infections, Fungal | 1 | 1997 | 99 | 0.130 |
Why?
|
| Angiomatosis | 1 | 2015 | 45 | 0.120 |
Why?
|
| Anterior Eye Segment | 1 | 1996 | 144 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2020 | 3737 | 0.120 |
Why?
|
| Trabeculectomy | 1 | 1997 | 174 | 0.120 |
Why?
|
| Aspergillosis | 1 | 1997 | 242 | 0.120 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2015 | 53 | 0.120 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 1995 | 72 | 0.120 |
Why?
|
| Eyelid Neoplasms | 1 | 1995 | 84 | 0.110 |
Why?
|
| Off-Label Use | 1 | 2016 | 185 | 0.110 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 1996 | 192 | 0.110 |
Why?
|
| Nurse's Role | 1 | 2015 | 187 | 0.110 |
Why?
|
| Orbital Neoplasms | 1 | 1995 | 223 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2020 | 10383 | 0.100 |
Why?
|
| Wet Macular Degeneration | 1 | 2015 | 164 | 0.100 |
Why?
|
| Retinal Neovascularization | 1 | 2015 | 289 | 0.100 |
Why?
|
| Sarcoidosis | 1 | 1998 | 532 | 0.100 |
Why?
|
| Eye Diseases | 1 | 1998 | 659 | 0.100 |
Why?
|
| Arteriovenous Fistula | 1 | 2015 | 311 | 0.100 |
Why?
|
| Macula Lutea | 2 | 2007 | 180 | 0.090 |
Why?
|
| Drug Compounding | 1 | 2012 | 235 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 2415 | 0.090 |
Why?
|
| Drug Contamination | 1 | 2012 | 152 | 0.090 |
Why?
|
| Injections | 2 | 2006 | 840 | 0.090 |
Why?
|
| Vitrectomy | 2 | 2006 | 389 | 0.090 |
Why?
|
| Ophthalmology | 1 | 2016 | 561 | 0.080 |
Why?
|
| Humans | 22 | 2024 | 765968 | 0.080 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1996 | 2203 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15652 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2020 | 8733 | 0.070 |
Why?
|
| Skin Diseases | 1 | 2015 | 1088 | 0.070 |
Why?
|
| Glaucoma, Neovascular | 1 | 2006 | 37 | 0.070 |
Why?
|
| Gonioscopy | 1 | 2006 | 157 | 0.060 |
Why?
|
| Fluorescein Angiography | 3 | 2015 | 1085 | 0.060 |
Why?
|
| Glaucoma Drainage Implants | 1 | 2006 | 107 | 0.060 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2006 | 192 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 1084 | 0.060 |
Why?
|
| Laser Coagulation | 2 | 2006 | 334 | 0.060 |
Why?
|
| Choroid | 1 | 2006 | 363 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 88835 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 3475 | 0.050 |
Why?
|
| Uveitis, Anterior | 1 | 2002 | 103 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 754 | 0.040 |
Why?
|
| Rod Opsins | 1 | 2000 | 108 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2021 | 42500 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2021 | 81514 | 0.040 |
Why?
|
| Vitreous Body | 1 | 2002 | 400 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2002 | 907 | 0.040 |
Why?
|
| Retina | 2 | 2020 | 2657 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 2 | 2015 | 2932 | 0.040 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2000 | 184 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7425 | 0.040 |
Why?
|
| Aged | 8 | 2020 | 171117 | 0.040 |
Why?
|
| Middle Aged | 9 | 2019 | 223009 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2006 | 3537 | 0.040 |
Why?
|
| Dacryocystitis | 1 | 1998 | 67 | 0.030 |
Why?
|
| Safety | 1 | 2002 | 1157 | 0.030 |
Why?
|
| Male | 8 | 2021 | 363698 | 0.030 |
Why?
|
| Lens Capsule, Crystalline | 1 | 1997 | 38 | 0.030 |
Why?
|
| Itraconazole | 1 | 1997 | 42 | 0.030 |
Why?
|
| Amphotericin B | 1 | 1997 | 140 | 0.030 |
Why?
|
| Pneumocystis | 1 | 1996 | 55 | 0.030 |
Why?
|
| United States | 2 | 2016 | 72903 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 1998 | 559 | 0.030 |
Why?
|
| Prevalence | 1 | 2013 | 15842 | 0.030 |
Why?
|
| Exudates and Transudates | 1 | 1996 | 173 | 0.030 |
Why?
|
| Ophthalmic Solutions | 1 | 1997 | 312 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 59889 | 0.030 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1996 | 239 | 0.030 |
Why?
|
| Incidence | 1 | 2013 | 21480 | 0.030 |
Why?
|
| Child | 2 | 2021 | 80564 | 0.030 |
Why?
|
| Conjunctiva | 1 | 1998 | 477 | 0.030 |
Why?
|
| Uveitis | 1 | 1998 | 398 | 0.030 |
Why?
|
| Adult | 5 | 2021 | 223044 | 0.030 |
Why?
|
| Sputum | 1 | 1996 | 513 | 0.030 |
Why?
|
| Female | 6 | 2021 | 396112 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 1993 | 142 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 4850 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 1997 | 769 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2015 | 65188 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 1998 | 1315 | 0.020 |
Why?
|
| Microscopy | 1 | 1996 | 901 | 0.020 |
Why?
|
| Glaucoma, Open-Angle | 1 | 1997 | 742 | 0.020 |
Why?
|
| Cartilage | 1 | 1993 | 798 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1998 | 2132 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1998 | 6309 | 0.020 |
Why?
|
| Biopsy | 1 | 1998 | 6763 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 4209 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1995 | 4893 | 0.010 |
Why?
|
| Rupture | 1 | 2006 | 443 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2006 | 15747 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1998 | 20659 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1996 | 5993 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 18293 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 12976 | 0.010 |
Why?
|
| Observer Variation | 1 | 2007 | 2615 | 0.010 |
Why?
|
| Disease Progression | 1 | 1998 | 13632 | 0.010 |
Why?
|
| Photochemotherapy | 1 | 2006 | 826 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 59489 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1998 | 36532 | 0.010 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2000 | 205 | 0.010 |
Why?
|
| Quality of Life | 1 | 2020 | 13462 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 1886 | 0.010 |
Why?
|
| Cell Count | 1 | 2000 | 1823 | 0.010 |
Why?
|
| Species Specificity | 1 | 2000 | 2406 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2000 | 1965 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 1718 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2000 | 1966 | 0.010 |
Why?
|
| Animals | 3 | 2002 | 168764 | 0.010 |
Why?
|
| Notochord | 1 | 1993 | 37 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 3446 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2000 | 12768 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2000 | 6220 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1993 | 964 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1993 | 824 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 20124 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1993 | 2266 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 17594 | 0.000 |
Why?
|
| Extremities | 1 | 1993 | 869 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 11022 | 0.000 |
Why?
|
| Prognosis | 1 | 2006 | 29922 | 0.000 |
Why?
|
| Collagen | 1 | 1993 | 2618 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2007 | 12240 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2007 | 54802 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2000 | 22332 | 0.000 |
Why?
|
| Gene Expression | 1 | 1993 | 7584 | 0.000 |
Why?
|
| Risk Factors | 1 | 2006 | 74840 | 0.000 |
Why?
|
| Mice | 1 | 2000 | 81819 | 0.000 |
Why?
|
| Brain | 1 | 1993 | 27171 | 0.000 |
Why?
|